吗丁啉品牌怎么样 申请店铺

我要投票 吗丁啉在保健药品行业中的票数:323 更新时间:2025-04-21
吗丁啉是哪个国家的品牌?「吗丁啉」是 西安杨森制药有限公司 旗下著名品牌。该品牌发源于陕西,由创始人ASGAR DAVID RANGOONWALA在1985期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力吗丁啉品牌出海!通过在本页面挂载吗丁啉品牌的产品链接和联系邮箱,可以提高吗丁啉产品曝光!跨境电商爆单神器,目前只要100元/年哦~

吗丁啉怎么样


【吗丁啉®】用于消化不良、腹胀、嗳气、恶心、呕吐、腹部胀痛。口服。成人一次1片,一日3次,饭前15-30分钟服用。本品为胃肠促动力药非处方药药品。请仔细阅读说明书并按说明使用或在药师指导下购买和使用。

成立于1985年的西安杨森制药有限公司,是美国强生公司在华最大的子公司,也是中国最大的合资制药企业之一。生产基地位于西安,在全国28个城市设有办事处,在华员工超过3,000人。

公司业务包括生产和销售高质量的药品,产品主要涉及胃肠病学、神经精神学、变态反应学、疼痛管理学、抗感染、生物制剂和肿瘤等领域;除此之外,公司还致力于提供与健康相关的服务及开展大众健康教育。

西安杨森制药有限公司着眼于未来,不断引进新的药品,并努力提高中国的医疗卫生水平,以服务广大的中国患者。

西安杨森工厂位于历史悠久的古城西安,是中国西北地区最早建立的中外合资制药企业的工厂。它占地170亩,建筑面积35,620平米,绿化面积约占52%。主要建筑物包括制剂车间、动力运行、污水处理中心、行政办公楼、综合办公楼、员工餐厅等。

西安杨森工厂在生产及管理上均达到了中国和欧洲的药品生产质量管理规范(GMP)的标准,达到了国际标准化组织ISO9001:2000标准质量管理体系及ISO14001标准环境管理体系要求,达到了OHSAS职业安全健康管理体系的要求,这些有利于西安杨森与国外在提供产品与服务方面的交流。同时,西安杨森工厂还采用国际通行的现代企业管理制度,引进了SAP系统进行战略和运营管理,以世界级的生产设备、高科技的检测技术、严密的质量体系、卓越的国际物流系统,完成从原材料进厂、制造、包装到成品检验出厂的全过程,并对所有环节均进行严格地质量监控。稳固、高效的供应链系统,严谨、流畅的生产系统,高效、安全的国际化配送系统,以及严格、稹密的质量保证系统,已经使西安杨森工厂成为了全球的国际化的生产中心。这里生产的产品剂型有片剂、胶囊剂、乳膏剂、液剂、栓剂和散剂,包装类型有管装、瓶装、袋装和铝塑包装。

1997年,西安杨森工厂率先通过国家药品GMP认证。1999年,获得德国莱茵公司ISO9002质量管理体系认证。2003年完成ISO9001:2000升级认证。2004年10月和2007年9月,西安杨森工厂顺利通过了欧盟GMP审计署的首次审核和再次审核,标志着我们的厂房、设备、环境、人员、文件体系及质量管理体系完全符合欧洲GMP的标准,同时也保证了西安杨森在医药领域的先进性与国际化。

为了更好地服务于客户,西安杨森还在工厂建立了一个跨部门协作中心――客户关爱中心(CustomerCareCenter,简称CCC),设立24小时热线,随时倾听来自客户的声音,及时处理与反馈客户咨询及投诉。客户关爱中心人员具备医学、药学背景和专业知识的培训,在沟通互动中不仅传递专业信息,同时也将强生信条中“对客户负责”的理念以实际行动传递给了客户,从而赢得了客户赞誉,并赢得未来。

相关链接:【吗丁啉®】药品说明>>


[morpholine ®] is used for dyspepsia, abdominal distention, belching, nausea, vomiting, abdominal distention and pain. Oral administration. Adults take one tablet three times a day 15-30 minutes before meals. This is an over-the-counter drug for gastrointestinal motility. Please read the manual carefully and use it according to the instructions or purchase and use it under the guidance of pharmacist. Founded in 1985, Xi'an Janssen Pharmaceutical Co., Ltd. is the largest subsidiary of Johnson & Johnson in China and one of the largest pharmaceutical joint ventures in China. The production base is located in Xi'an, with offices in 28 cities and more than 3000 employees in China. The company's business includes the production and sale of high-quality drugs. Its products mainly involve Gastroenterology, neuropsychology, allergy, pain management, anti infection, biological agents and tumors. In addition, the company is committed to providing health-related services and developing public health education. Xi'an YANGSEN Pharmaceutical Co., Ltd. focuses on the future, constantly introduces new drugs, and strives to improve China's medical and health level to serve the vast number of Chinese patients. Located in the ancient city of Xi'an with a long history, Xi'an Janssen factory is the first Sino foreign joint venture pharmaceutical enterprise in Northwest China. It covers an area of 170 mu, with a building area of 35620 square meters and a greening area of about 52%. The main buildings include preparation workshop, power operation, sewage treatment center, administrative office building, comprehensive office building, staff restaurant, etc. In terms of production and management, Xi'an Janssen factory has reached the GMP standards of China and Europe, the ISO 9001:2000 standard quality management system and ISO14001 standard environmental management system, and the OHSAS occupational safety and health management system, which are conducive to the products and services provided by Xi'an Janssen and foreign countries Face to face communication. At the same time, Xi'an Janssen plant also adopts the internationally accepted modern enterprise management system and introduces SAP system for strategic and operational management. With world-class production equipment, high-tech testing technology, strict quality system and excellent international logistics system, it completes the whole process from raw material entering the plant, manufacturing, packaging to finished product inspection and leaving the factory, and strictly carries out all links Ground quality monitoring. A stable and efficient supply chain system, a rigorous and smooth production system, an efficient and safe international distribution system, and a strict and strict quality assurance system have made Xi'an YANGSEN factory a global international production center. The products produced here are tablets, capsules, creams, liquids, suppositories and powders. The packaging types include tube, bottle, bag and aluminum plastic packaging. In 1997, Xi'an Janssen factory took the lead in passing the national GMP certification. In 1999, it obtained the ISO9002 quality management system certification of German Rhine company. In 2003, ISO9001:2000 upgrade certification was completed. In October 2004 and September 2007, the Xi'an Yang Sen factory successfully passed the first audit and re examination of the GMP Audit Office of the European Union, marking that our factory buildings, equipment, environment, personnel, file system and quality management system fully comply with the European GMP standard, and also guaranteed the advanced nature and internationalization of Yang Sen in the field of medicine in Xi'an. In order to better serve customers, Xi'an Janssen has also established a cross department cooperation center customer care center (CCC) in the factory. It has set up a 24-hour hotline to listen to the voice from customers at any time, handle and feedback customer consultation and complaints in a timely manner. The staff of the customer care center have the training of medical and pharmaceutical background and professional knowledge. In the communication and interaction, they not only pass the professional information, but also pass the concept of "being responsible for customers" in Johnson's creed to the customers with practical actions, so as to win the praise of customers and win the future. Related links: [domperidone ®] Drug Description & gt; & gt;

本文链接: https://brand.waitui.com/5009730e4.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

一季度多地离境退税商品销售额同比大增

国家税务总局重庆市税务局近日公布的数据显示,2025年一季度,重庆市离境退税商品销售额、办理离境退税金额均同比增长近5倍。国家税务总局北京市税务局数据显示,2025年一季度,北京市开具离境退税申请单份数同比增长128%,离境退税商品销售额2.7亿元,同比翻一番。中国城市专家智库委员会常务副秘书长林先平表示:“多地离境退税商品销售额大增,主要得益于我国优质的商品和服务供给。此外,各地积极打造多元消费场景,创新服务举措。我国入境游产业蓬勃发展,未来离境退税市场空间广阔,相关企业有望迎来发展红利。”(证券日报)

41分钟前

模拟芯片行业“深蹲起跳”,基金守得云开见月明

在中国反制美国所谓“对等关税”的背景下,国内模拟芯片公司的动向备受市场关注。近期,A股模拟芯片概念股走出了独立反弹行情,成为表现亮眼的细分赛道之一。比如,信号链佼佼者思瑞浦涨幅翻倍,国内模拟芯片设计龙头圣邦股份、隔离芯片提供者纳芯微等涨幅也超过了50%。由于产品种类多,下游应用广泛,模拟芯片行业曾被不少基金经理认为是长坡厚雪的优质赛道。作为国内少有的自给率较低的行业,模拟芯片龙头公司也成为不少知名科技投资基金经理的“座上宾”。不过,过去几年受全球半导体行业景气周期下行的影响,模拟芯片行业面临着严峻挑战,相关公司股价的表现也跌宕起伏。在此背景下,多数基金经理仍然选择坚定持有,如今随着行业完成“深蹲起跳”也守得云开见月明。(证券时报)

41分钟前

多地推进土储专项债发行,执行效果仍需政策优化与配套保障

今年以来,土地储备专项债发行持续推进,成为地方政府调节土地供需、稳定房地产市场、缓解债务压力的重要抓手。数据显示,截至4月初,全国已公告拟通过专项债收购存量土地的金额超1800亿元,北京、广东、湖南等地率先启动发行。多位业内人士认为,土地专项债不仅有助于消化闲置地块、改善土地市场结构,也为房企盘活资产、城投化解高息债务提供了资金支持。尽管政策端持续优化,专项债执行效果仍需在收益机制、区域协调与风险防控等方面加强配套,以实现“稳市场、稳地价、稳预期”的政策目标。(上证报)

41分钟前

年报季调研忙,机构探寻A股公司新增长点

机构投资者趁着年报披露窗口期打开,纷纷走进上市公司展开调研,电子、机械设备、医药生物三大行业成为机构调研的“热土”。其中,不少公司同时开放线上线下的调研模式,在同一时间吸引上百家机构的目光。受益于市场需求拉动,芯片、商业航空、智能穿戴等细分赛道有望加快产品及项目交付。面对美国“对等关税”挑战,汽车、光伏、电子等多个行业公司纷纷亮出海外成绩单,表现出坚定的出海决心。同时,一批外资机构热衷于调研机器人、AI产业链公司,密切关注产业替代、政策机遇等新动态。(上证报)

41分钟前

境外机构持续加码中国债市

近段时间以来,境外机构持续积极参与中国债券市场。中国人民银行(以下简称“央行”)数据显示,截至4月15日,共有1160余家境外机构进入中国债券市场,境外机构在我国持有债券总量为4.5万亿元,较2024年末增加2700多亿元。我国债券市场总规模已达到183万亿元,居世界第二位。(证券日报)

41分钟前

本页详细列出关于众友医药的品牌信息,含品牌所属公司介绍,众友医药所处行业的品牌地位及优势。
咨询